Heartflow, Inc.
HTFL- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001464521
In the last 90 days, Heartflow, Inc. insiders filed 0 open-market purchases and 14 sales; 194 institutions reported holding it in 13F filings for Q2 2026, worth $2.19B in total; no superinvestor holds it.
Key figures
- Market capClose on Nov 11, 2026
- $5.14B
- Insider buysOpen market, last 90 days
- 0
- Insider sellsLast 90 days, $17.2M in total
- 14
- 13F holdersQ2 2026, +27 vs. previous quarter
- 194
- 13F valueReported value at the end of Q2 2026
- $2.19B
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Financials
See financial statementsFrom SEC filings, in USD.
- Revenue, FY2025
- $176.0M
- No comparable prior period
- Net income, FY2025
- -$116.8M
- No comparable prior period
- Free cash flow, FY2025
- -$59.0M
- No comparable prior period
- Revenue, Q2 FY2026
- $64.1M
- +47.6% year over year
Revenue flow, FY2025
Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue.
Net loss for FY2025: $116.8M (66.3% of revenue).
Short interest
See short dataFrom FINRA, settlement date Oct 30, 2026.
- Short interest
- 5.69M
- Shares sold short
- Change
- −1.64M
- −22.4% vs. previous
- Days to cover
- 3.51
- At average daily volume
Superinvestors holding HTFL, Q2 2026
Go to the superinvestors tabNo superinvestor reported holding HTFL at the end of Q2 2026.
Latest insider trades
See all insider tradesOpen-market purchases and sales by Heartflow, Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 10, 2026 (view filing)6:59 PM ET | Nov 10 | Same day | Farquhar John C.M.Chief Executive Officer | SSale | −38.9K | $55.74 | −$2.17M | −13.4%252.0K after | 10b5-1 |
| Nov 10, 2026 (view filing)6:52 PM ET | Nov 9 | 1 day | Verghese VikramChief Financial Officer | SSaleCommon Stock. | −3.59K | $53.15 | −$190.6K | −2.3%149.6K after | 10b5-1 |
| Oct 26, 2026 (view filing)6:00 PM ET | Oct 22 | 4 days | Rogers CampbellChief Medical Officer | SSale | −23.9K | $55.01 | −$1.32M | −24.6%73.5K after | 10b5-1 |
| Oct 14, 2026 (view filing)6:05 PM ET | Oct 12 | 2 days | Farquhar John C.M.Chief Executive Officer | SSale | −38.9K | $49.57 | −$1.93M | −12.1%283.0K after | 10b5-1 |
| Sep 21, 2026 (view filing)6:19 PM ET | Sep 18 | 3 days | Rogers CampbellChief Medical Officer | SSale | −19.7K | $50.15 | −$987.1K | −19.8%80.0K after | 10b5-1 |
| Sep 18, 2026 (view filing)8:46 PM ET | Sep 17-18 | 1 day | Verghese VikramChief Financial Officer | SSaleCommon Stock. | −24.3K | $50.55 | −$1.23M | −13.6%155.2K after | 2 lots10b5-1 |
| Sep 15, 2026 (view filing)7:44 PM ET | Sep 11-15 | 4 days | Verghese VikramChief Financial Officer | SSaleCommon Stock. | −35.0K | $50.08 | −$1.75M | −16.3%179.5K after | 3 lots10b5-1 |
| Sep 14, 2026 (view filing)6:41 PM ET | Sep 10-11 | 4 days | Farquhar John C.M.Chief Executive Officer | SSale | −38.9K | $46.78 | −$1.82M | −10.8%321.9K after | 2 lots10b5-1 |
| Sep 10, 2026 (view filing)5:24 PM ET | Sep 8 | 2 days | Verghese VikramChief Financial Officer | SSaleCommon Stock. | −6.64K | $50.03 | −$332.2K | −3.0%214.5K after | 10b5-1 |
| Sep 4, 2026 (view filing)5:29 PM ET | Sep 2-3 | 2 days | Verghese VikramChief Financial Officer | SSaleCommon Stock. | −33.4K | $49.85 | −$1.67M | −13.1%221.1K after | 2 lots10b5-1 |
Top 10 13F holders, Q2 2026
See all 194 holdersThe largest institutional positions in Heartflow, Inc. at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 8,448,158 | $247.9M | 14.74% | −2,000,000−19.1% | Reduced |
| Wellington Management Group LLP | 7,864,226 | $230.7M | 0.04% | −4,118,057−34.4% | Reduced |
| BlackRock, Inc. | 5,197,747 | $152.5M | 0.00% | +3,735,163+255.4% | Added |
| FMR LLC | 4,820,944 | $141.4M | 0.01% | −576,858−10.7% | Reduced |
| Vanguard Portfolio Management LLC | 3,584,428 | $105.2M | 0.00% | +1,538,490+75.2% | Added |
| Bamco Inc | 3,225,133 | $94.6M | 0.14% | −602,398−15.7% | Reduced |
| Vanguard Capital Management LLC | 2,753,206 | $80.8M | 0.00% | +859,711+45.4% | Added |
| Jupiter Topco LLC | 2,419,336 | $71.0M | 0.03% | +2,419,336 | New |
| Invesco Ltd. | 2,298,718 | $67.4M | 0.01% | +385,628+20.2% | Added |
| Point72 Asset Management, L.P. | 1,721,279 | $50.5M | 0.08% | +1,182,928+219.7% | Added |
Holders of 5% or more of HTFL
See all 4 holders and filingsHolders whose latest Schedule 13D or 13G filing reports 5% or more of Heartflow, Inc..
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| BCLS Fund III Investments, LP | 13G/A | 9.80%8.45M shares | −2.38 ppfrom 12.18% | Nov 14, 20253 filings | Aug 14, 2026 | SEC |
| Wellington Management Group LLP | 13G/A | 9.10%7.86M shares | −1.60 ppfrom 10.70% | Nov 12, 20255 filings | Aug 13, 2026 | SEC |
| BlackRock, Inc. | 13G | 5.70%4.93M shares | New | Jul 28, 20261 filing | Jul 28, 2026 | SEC |
| FMR LLC | 13G | 5.70%4.73M shares | New | Nov 5, 20251 filing | Nov 5, 2025 | SEC |